| Literature DB >> 31712326 |
Fijs W B van Leeuwen1,2, Margret Schottelius3, Oscar R Brouwer4,2, Sergi Vidal-Sicart5, Samuel Achilefu6, Joachim Klode7, Hans-Jurgen Wester5, Tessa Buckle4,2.
Abstract
By contributing to noninvasive molecular imaging and radioguided surgery, nuclear medicine has been instrumental in the realization of precision medicine. During the last decade, it has also become apparent that nuclear medicine (e.g., in the form of bimodal/hybrid tracers) can help to empower fluorescence-guided surgery. More specifically, when using hybrid tracers, lesions can be noninvasively identified and localized with a high sensitivity and precision (guided by the radioisotope) and ultimately resected under real-time optical guidance (fluorescent dye). This topical review discusses early clinical successes, preclinical directions, and key aspects that could have an impact on the future of this field.Keywords: bimodal tracers; fluorescence imaging; image-guided surgery; multimodal; nuclear medicine
Year: 2019 PMID: 31712326 DOI: 10.2967/jnumed.119.228684
Source DB: PubMed Journal: J Nucl Med ISSN: 0161-5505 Impact factor: 10.057